Recent evidence suggests that the disruptive effects of acute exposure to (+/-)3,4-methylene dioxymethamphetamine (MDMA) on memory performance may be the result of increased confusion between previous-trial and current-trial events. The current study tested this hypothesis by examining the effects of MDMA on performance of rats in a delayed matching-to-sample procedure when the length of the intertrial interval (ITI) was altered. Consistent with the possibility that limiting the conditions under which responses made on a previous trial would interfere with current-trial choice, a 15-s ITI ameliorated the disruptive effects caused by MDMA on trial performance when the ITI was 5 s. Therefore, the disruptive effects of MDMA on memory can be attenuated by methods that separate current-trial "to-be-remembered" events from previous-trial events.